Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 24, 1994 - Issue 20
37
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis of 1,2-Epoxy-3-alkanols via Mitsunobu Reaction on Unprotected Enantiopure Acyclic 1,2,3-Triols

, &
Pages 2843-2850 | Received 29 Mar 1994, Published online: 23 Sep 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

DavidL. Hughes. (1996) PROGRESS IN THE MITSUNOBU REACTION. A REVIEW. Organic Preparations and Procedures International 28:2, pages 127-164.
Read now

Articles from other publishers (3)

C. GRAVIER‐PELLETIER, Y. LE MERRER & J.‐C. DEPEZAY. (2010) ChemInform Abstract: Synthesis of 1,2‐Epoxy‐3‐alkanols via Mitsunobu Reaction on Unprotected Enantiopure Acyclic 1,2,3‐Triols.. ChemInform 26:15.
Crossref
Christine Gravier-Pelletier, Yves Le Merrer & Jean-Claude Depezay. (1995) Enantiopure hydroxylactones from L-ascorbic and D-isoascorbic acids. Part II. Synthesis of (−)-(5R, 6S)-6-acetoxy-5-hexadecanolide and its diastereomers. Tetrahedron 51:6, pages 1663-1674.
Crossref
Michèle Sanière, Isabelle Charvet, Yves Le Merrer & Jean-Claude Depezay. (1995) Enantiopure hydroxylactones from L-ascorbic and D-isoascorbic acids. Part I. Synthesis of (−)-muricatacin. Tetrahedron 51:6, pages 1653-1662.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.